PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
PET-MRI: Evaluation, Optimization and Clinical Implementation
Sponsor: Case Comprehensive Cancer Center
Listed as NCT02084147, this NA trial focuses on Cardiac Disease and Dementia and remains completed. Sponsored by Case Comprehensive Cancer Center, it has been updated 13 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Nov 2019 — Feb 2020 [monthly]
Completed NA
Status: Suspended → Completed
-
Jun 2018 — Nov 2019 [monthly]
Suspended NA
-
Nov 2017 — Jun 2018 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
May 2017 — Nov 2017 [monthly]
Recruiting NA
-
Feb 2017 — May 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Case Comprehensive Cancer Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .